Medicure Inc. MCUJF
2.97 USD -0.08 (-2.62%)
At closeNov 3, 2026, 4:00 PM EST
2.91 Day range 3.00
0.67 52-week range 3.45
- YTD
- +271.25%
- 1 year
- +230.00%
- Market cap
- 33.28M
- EPS (ttm)
- -0.53
- YTD return
- +271.25%
- 1-year return
- +230.00%
- Volume
- 12.00K
- Avg volume
- 12.97K
- Open
- 2.91
- Previous close
- 3.05
- Day's range
- 2.91 – 3.00
- 52-week range
- 0.67 – 3.45
2Y +2.30 (+365.08%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 25, 2024 | Sep 1, 2024 | 0.00 | 0.05 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.09 | — | — |
| May 28, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Apr 8, 2024 | Dec 1, 2023 | 0.00 | -0.10 | — | — |
| Nov 21, 2023 | Sep 1, 2023 | 0.00 | 0.01 | — | — |
| Jul 28, 2023 | Jun 1, 2023 | 0.00 | 0.01 | — | — |
News
Medicure (OTCMKTS:MCUJF) Share Price Breaks Above 50-Day Moving Average – What’s Next? 
Medicure (OTCMKTS:MCUJF) Shares Break Above 50-Day Moving Average – Time to Sell? 
Medicure Announces Grant of Stock Options 
Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial 
Medicure (OTCMKTS:MCUJF) Shares Cross Above 50-Day Moving Average – Should You Sell? 
Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress 
Medicure Inc. (MPH:CA) Q2 2026 Earnings Call Prepared Remarks Transcript 
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call 
Comparing Medicure (OTCMKTS:MCUJF) & Takeda Pharmaceutical (NYSE:TAK) 
Medicure Announces CFO Change
Your note
Sign in to keep a note on MCUJF — it syncs with the Stock Master app.